BioXcel Therapeutics, Inc. short interest in 2019

In 2019, BioXcel Therapeutics, Inc.'s disclosed short interest ran from 2.61% of shares outstanding on 15 Oct 2019 to 3.30% on 31 Dec 2019, a change of +0.69 percentage points. The year's high was 3.34% on 29 Nov 2019 and its low 2.61% on 15 Oct 2019, averaging 3.11% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.53 days on 15 Nov 2019. Full history: BioXcel Therapeutics, Inc..

Cite this page

Plain

Short position data for BioXcel Therapeutics, Inc. short interest in 2019: FINRA, compiled by howshorted.com, settlement date 31 Dec 2019. https://howshorted.com/us/company/btai/2019/

Wikipedia

<ref>{{cite web |title=BioXcel Therapeutics, Inc. short interest in 2019 short position data |url=https://howshorted.com/us/company/btai/2019/ |website=HowShorted |publisher=howshorted.com (data: FINRA) |date=2019-12-31 |access-date=2026-10-13}}</ref>

BibTeX

@misc{howshorted-bioxcel-therapeutics-inc-short-interest--2019-12-31,
  title        = {BioXcel Therapeutics, Inc. short interest in 2019 short position data},
  author       = {{HowShorted}},
  howpublished = {\url{https://howshorted.com/us/company/btai/2019/}},
  note         = {Data: FINRA, settlement date 31 Dec 2019; accessed 2026-10-13},
  year         = {2019}
}

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

2019 in figures

Start of year: 2.61% (15 Oct 2019)
End of year: 3.30% (31 Dec 2019)
Change: +0.69 pp
High: 3.34% (29 Nov 2019)
Low: 2.61% (15 Oct 2019)
Average: 3.11%
Highest days to cover: 6.53 (15 Nov 2019)

Every report in 2019

BioXcel Therapeutics, Inc. short interest in 2019
Settlement	Short interest	Days to cover
15 Oct 2019	2.61%	5.74
31 Oct 2019	3.12%	6.02
15 Nov 2019	3.08%	6.53
29 Nov 2019	3.34%	2.28
13 Dec 2019	3.23%	6.05
31 Dec 2019	3.30%	2.57

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.